|
Volumn 25, Issue 139, 2016, Pages 19-28
|
The role of moxifloxacin in tuberculosis therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MOXIFLOXACIN;
QUINOLONE DERIVATIVE;
TUBERCULOSTATIC AGENT;
ANIMAL;
COMBINATION DRUG THERAPY;
DRUG EFFECTS;
DRUG REPOSITIONING;
HUMAN;
LUNG;
MICROBIOLOGY;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
TREATMENT OUTCOME;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
TUBERCULOSIS, PULMONARY;
ANIMALS;
ANTIBIOTICS, ANTITUBERCULAR;
DRUG REPOSITIONING;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUG THERAPY, COMBINATION;
FLUOROQUINOLONES;
HUMANS;
LUNG;
MYCOBACTERIUM TUBERCULOSIS;
TREATMENT OUTCOME;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
TUBERCULOSIS, PULMONARY;
|
EID: 85015457454
PISSN: None
EISSN: 16000617
Source Type: Journal
DOI: 10.1183/16000617.0085-2015 Document Type: Review |
Times cited : (58)
|
References (0)
|